127 related articles for article (PubMed ID: 30031020)
1. EZH2 is upregulated in the proliferation centers of CLL/SLL lymph nodes.
Szurián K; Csala I; Marosvári D; Rajnai H; Dezső K; Bödör C; Piurkó V; Matolcsy A; Reiniger L
Exp Mol Pathol; 2018 Oct; 105(2):161-165. PubMed ID: 30031020
[TBL] [Abstract][Full Text] [Related]
2. Quantitative miR analysis in chronic lymphocytic leukaemia/small lymphocytic lymphoma - proliferation centres are characterized by high miR-92a and miR-155 and low miR-150 expression.
Szurián K; Csala I; Piurkó V; Deák L; Matolcsy A; Reiniger L
Leuk Res; 2017 Jul; 58():39-42. PubMed ID: 28407516
[TBL] [Abstract][Full Text] [Related]
3. PD-1 Expression in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) and Large B-cell Richter Transformation (DLBCL-RT): A Characteristic Feature of DLBCL-RT and Potential Surrogate Marker for Clonal Relatedness.
He R; Ding W; Viswanatha DS; Chen D; Shi M; Van Dyke D; Tian S; Dao LN; Parikh SA; Shanafelt TD; Call TG; Ansell SM; Leis JF; Mai M; Hanson CA; Rech KL
Am J Surg Pathol; 2018 Jul; 42(7):843-854. PubMed ID: 29762141
[TBL] [Abstract][Full Text] [Related]
4. miRNA analysis in B-cell chronic lymphocytic leukaemia: proliferation centres characterized by low miR-150 and high BIC/miR-155 expression.
Wang M; Tan LP; Dijkstra MK; van Lom K; Robertus JL; Harms G; Blokzijl T; Kooistra K; van T'veer MB; Rosati S; Visser L; Jongen-Lavrencic M; Kluin PM; van den Berg A
J Pathol; 2008 May; 215(1):13-20. PubMed ID: 18348159
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic silencing of miR-26A1 in chronic lymphocytic leukemia and mantle cell lymphoma: Impact on EZH2 expression.
Kopparapu PK; Bhoi S; Mansouri L; Arabanian LS; Plevova K; Pospisilova S; Wasik AM; Croci GA; Sander B; Paulli M; Rosenquist R; Kanduri M
Epigenetics; 2016 May; 11(5):335-43. PubMed ID: 27052808
[TBL] [Abstract][Full Text] [Related]
6. Cyclin D1 expression by histiocytes may mimic cyclin D1-positive proliferation centres of chronic lymphocytic leukaemia/small lymphocytic lymphoma.
Wu J; Zhang Y; Sun L; Zhai Q
Pathol Res Pract; 2018 Jan; 214(1):72-75. PubMed ID: 29254788
[TBL] [Abstract][Full Text] [Related]
7. The histone methyltransferase EZH2 as a novel prosurvival factor in clinically aggressive chronic lymphocytic leukemia.
Papakonstantinou N; Ntoufa S; Chartomatsidou E; Kotta K; Agathangelidis A; Giassafaki L; Karamanli T; Bele P; Moysiadis T; Baliakas P; Sutton LA; Stavroyianni N; Anagnostopoulos A; Makris AM; Ghia P; Rosenquist R; Stamatopoulos K
Oncotarget; 2016 Jun; 7(24):35946-35959. PubMed ID: 27191993
[TBL] [Abstract][Full Text] [Related]
8. Proliferation centers in bone marrows involved by chronic lymphocytic leukemia/small lymphocytic lymphoma: a clinicopathologic analysis.
Chang JC; Harrington AM; Olteanu H; VanTuinen P; Kroft SH
Ann Diagn Pathol; 2016 Dec; 25():15-19. PubMed ID: 27806839
[TBL] [Abstract][Full Text] [Related]
9. The proliferation center microenvironment and prognostic markers in chronic lymphocytic leukemia/small lymphocytic lymphoma.
Soma LA; Craig FE; Swerdlow SH
Hum Pathol; 2006 Feb; 37(2):152-9. PubMed ID: 16426914
[TBL] [Abstract][Full Text] [Related]
10. EZH2 upregulates the PI3K/AKT pathway through IGF1R and MYC in clinically aggressive chronic lymphocytic leukaemia.
Kosalai ST; Morsy MHA; Papakonstantinou N; Mansouri L; Stavroyianni N; Kanduri C; Stamatopoulos K; Rosenquist R; Kanduri M
Epigenetics; 2019 Nov; 14(11):1125-1140. PubMed ID: 31216925
[TBL] [Abstract][Full Text] [Related]
11. [Clinical significance of ZAP-70 protein expression in chronic lymphocytic leukemia/small lymphocytic lymphoma].
Qi RJ; Zhang PH; Qiu LG; Fang LH; Yang QY; Sun FJ; Chen HS
Zhonghua Bing Li Xue Za Zhi; 2009 May; 38(5):329-32. PubMed ID: 19575876
[TBL] [Abstract][Full Text] [Related]
12. Immunophenotype does not correlate with lymph node histology in chronic lymphocytic leukemia/small lymphocytic lymphoma.
Asplund SL; McKenna RW; Howard MS; Kroft SH
Am J Surg Pathol; 2002 May; 26(5):624-9. PubMed ID: 11979092
[TBL] [Abstract][Full Text] [Related]
13. Most morphologic features in chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) do not reliably predict underlying FISH genetics or immunoglobulin heavy chain variable region somatic mutational status.
Garcia CF; Hunt KE; Kang H; Babb A; Gale JM; Vasef MA; Reichard KK
Appl Immunohistochem Mol Morphol; 2010 Mar; 18(2):119-27. PubMed ID: 19826250
[TBL] [Abstract][Full Text] [Related]
14. High rate of neoplastic cells with genetic abnormalities in proliferation centers of chronic lymphocytic leukemia.
Balogh Z; Reiniger L; Rajnai H; Csomor J; Szepesi A; Balogh A; Deák L; Gagyi E; Bödör C; Matolcsy A
Leuk Lymphoma; 2011 Jun; 52(6):1080-4. PubMed ID: 21417824
[TBL] [Abstract][Full Text] [Related]
15. Control of PD-L1 expression in CLL-cells by stromal triggering of the Notch-c-Myc-EZH2 oncogenic signaling axis.
Böttcher M; Bruns H; Völkl S; Lu J; Chartomatsidou E; Papakonstantinou N; Mentz K; Büttner-Herold M; Zenz T; Herling M; Huber W; Ghia P; Stamatopoulos K; Mackensen A; Mougiakakos D
J Immunother Cancer; 2021 Apr; 9(4):. PubMed ID: 33931470
[TBL] [Abstract][Full Text] [Related]
16. Herpes simplex infection simulating Richter transformation: a series of four cases and review of the literature.
Salem A; Loghavi S; Khoury JD; Agbay RL; Jorgensen JL; Medeiros LJ
Histopathology; 2017 Apr; 70(5):821-831. PubMed ID: 27905140
[TBL] [Abstract][Full Text] [Related]
17. Apoptotic and proliferative characteristics of proliferation centers in lymph node sections of patients with chronic lymphocytic leukemia.
Sachanas S; Levidou G; Angelopoulou MK; Moschogiannis M; Yiakoumis X; Kalpadakis C; Vassilakopoulos TP; Kontopidou F; Tsirkinidis P; Dimitrakopoulou A; Kokoris S; Dimitriadou E; Kyrtsonis MC; Panayiotidis P; Papadaki H; Patsouris E; Korkolopoulou P; Pangalis GA
Leuk Lymphoma; 2014 Mar; 55(3):571-82. PubMed ID: 23697878
[TBL] [Abstract][Full Text] [Related]
18. Chronic lymphocytic leukemia with proliferation centers in bone marrow is associated with younger age at initial presentation, complex karyotype, and TP53 disruption.
Garces S; Khoury JD; Kanagal-Shamanna R; Salem A; Wang SA; Ok CY; Hu S; Patel KP; Routbort MJ; Luthra R; Tang G; Schlette EJ; Bueso-Ramos CE; Medeiros LJ; Loghavi S
Hum Pathol; 2018 Dec; 82():215-231. PubMed ID: 30086334
[TBL] [Abstract][Full Text] [Related]
19. Hsa-miR-15a and Hsa-miR-16-1 expression is not related to proliferation centers abundance and other prognostic factors in chronic lymphocytic leukemia.
Rossi M; Fuligni F; Ciccone M; Agostinelli C; Righi S; Luciani M; Laginestra MA; Rigolin GM; Sapienza MR; Gazzola A; Mannu C; Cuneo A; Pileri S; Piccaluga PP
Biomed Res Int; 2013; 2013():715391. PubMed ID: 24392455
[TBL] [Abstract][Full Text] [Related]
20. CCL3 chemokine expression by chronic lymphocytic leukemia cells orchestrates the composition of the microenvironment in lymph node infiltrates.
Hartmann EM; Rudelius M; Burger JA; Rosenwald A
Leuk Lymphoma; 2016; 57(3):563-71. PubMed ID: 26458057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
